Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, Bruno Sangro, Jordi Bruix, Marco Sanduzzi-Zamparelli, Wacław Hołówko, Mohamed El Kassas, Tudor Mocan, Mohamed Bouattour, Philippe Merle, Frederik J.H. Hoogwater, Saleh A. Alqahtani, Helen L. Reeves, David J. Pinato, Emmanouil Giorgakis, Tim MeyerGerda Elisabeth Villadsen, Henning Wege, Massimiliano Salati, Beatriz Mínguez, Giovan Giuseppe Di Costanzo, Christoph Roderburg, Frank Tacke, María Varela, Peter R. Galle, Mario Reis Alvares-da-Silva, Jörg Trojan, John Bridgewater, Giuseppe Cabibbo, Christian Toso, Anja Lachenmayer, Andrea Casadei-Gardini, Hidenori Toyoda, Tom Lüdde, Rosanna Villani, Ana María Matilla Peña, Cassia Regina Guedes Leal, Monica Ronzoni, Manuel Delgado, Christie Perelló, Sonia Pascual, José Luis Lledó, Alessandro Granito, Giovanni Brandi, Maria Guarino, Massimo Iavarone, Maria Reig

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Assessing the impact of COVID-19 on liver cancer management (CERO-19)'. Together they form a unique fingerprint.

Medicine & Life Sciences